帝王国际投资2025年年报

(formerly known as Life Healthcare Group Limited) ANNUAL REPORT年度報告 Contents目 錄 Corporate Information2Management Discussion and Analysis5Biographical Details of Directors and Senior Management30Directors’ Report33Corporate Governance Report50Independent Auditor’s Report79Consolidated Statement of Profit or Loss andOther Comprehensive Income90Consolidated Statement of Financial Position92Consolidated Statement of Changes in Equity94Consolidated Statement of Cash Flows95Notes to the Consolidated Financial Statements97Five Year Financial Summary180 Corporate Information公 司 資 料 EXECUTIVE DIRECTORS Mr. Leng Yueyingtan(Chairman) (appointed on 20 December 2024) Mr. Wang MengyaoMr. Li Li (appointed on 19 September 2024,re-designated as Non-Executive Director on 6 January 2025 andredesignated as Executive Director on 13 June 2025) Mr. Man Wai LunMs. Yan Ming (appointed as Independent Non-Executive Directoron 23 August 2023, re-designated as Executive Directoron 19 March 2024 and suspended on 24 April 2025) INDEPENDENT NON-EXECUTIVE DIRECTORS Mr. Lou TaoMr. Wang ZhenyuMr. Liu Zhong (appointed on 19 September 2024) Ms. Yang Xilin (resigned on 10 April 2025) AUDIT COMMITTEE Mr. Leng Yueyingtan (appointed on 6 January 2025) Mr. Liu Zhong (appointed on 19 September 2024) Mr. Wang Zhenyu (resigned on 6 January 2025) Ms. Yang Xilin (resigned on 10 April 2025) REMUNERATION COMMITTEE Mr. Leng Yueyingtan (appointed on 6 January 2025) Mr. Liu Zhong (appointed on 10 April 2025) Ms. Yang Xilin (resigned on 10 April 2025) Mr. Li Li (resigned on 6 January 2025) NOMINATION COMMITTEE Mr. Leng Yueyingtan(Chairman) (appointed on 6 January 2025) Mr. Man Wai LunMs. Yang Xilin (resigned on 10 April 2025) Mr. Liu Zhong (resigned on 6 January 2025) AUTHORISED REPRESENTATIVESMr. Wang MengyaoMr. Wong Ka Sing COMPANY SECRETARYMr. Wong Ka Sing 38223 AUDITOR ZHONGHUI ANDA CPA Limited23/F, Tower 2, Enterprise Square Five38 Wang Chiu RoadKowloon Bay, KowloonHong Kong PRINCIPAL BANKERBank of Communications (Hong Kong) Limited Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman KY1-1111Cayman Islands REGISTERED OFFICE Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman KY1-1111Cayman Islands 15111101 PRINCIPAL OFFICE IN HONG KONG 1101, 11th Floor,Gloucester Tower, The Landmark,15 Queen’s Road Central,Hong Kong Corporate Information公 司 資 料 www.kinginternational.hk COMPANY’S WEBSITEwww.kinginternational.hk CAYMAN ISLANDS PRINCIPAL SHAREREGISTRAR AND TRANSFER OFFICE Suntera (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand CaymanKY1-1111Cayman Islands Suntera (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand CaymanKY1-1111Cayman Islands HONG KONG BRANCH SHARE REGISTRARAND TRANSFER OFFICE 1617 Tricor Tengis Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong 00928 LISTING INFORMATIONThe Stock Exchange of Hong Kong LimitedStock Code: 00928 Management Discussion and Analysis管 理 層 討 論 及 分 析 On behalf of King International Investment Limited (the “Company”),I present to the shareholders the results of the Company and itssubsidiaries (collectively referred to as the “Group”) for the year ended31 March 2025. OVERVIEW The Company is an investment holding company. The Company and itssubsidiaries (the “Group”) are principally engaged in healthcare productsand services business, money lending business and sales of liquorBusiness. On one hand, the Company, through its subsidiaries, provides medicalsupplies including medical thermometers, masks, protective clothing,disinfectant, virus testing kits and reagents, breathing machines and othermedical products, and also provides value-added services in respectof the procurement of such medical supplies and products includingproviding market intelligence, sourcing of bids, comparative assessmentof technical specifications and cost analysis, and negotiation of terms ofsupply. The Group continued to developing domestic healthcare equipmentser vice business. Taking advantage of its own advantages, the Groupintegrates health data analysis software and healthcare equipment toprovide new healthcare services and products business, which has beenrecognized by the industry. The Group also expands its business totrading of hygiene products to ride on the demand for personal andhousehold hygiene due to the growing awareness among consumers inthe wake of the COVID-19 pandemic. Following the deconsolidation ofcertain subsidiaries, the Company shifted its business to Hainan LuckyLight Brand Management Co., Ltd.to operate the healthcare business. The Company has been tradingdisinfectant water since April 1, 2025, which has contributed considerablerevenue to the healthcare segment. The Company believes that thetrading of disinfectant water will continue to grow and will become asignificant component of the healthcare segment. Management Discussion and Analysis管 理 層 討 論 及 分 析 100.00% Due to the allocation of resources for the new bus